Cargando…
Application of mTORC1 Inhibitors for Tissue-Agnostic Management of Standard-Therapy-Refractory Solid Tumors
SIMPLE SUMMARY: Hyperactivation of the mTOR pathway is a common occurrence in malignancies. This study investigated the clinical benefit of the tissue-agnostic application of mTOR inhibitors for the therapeutic management of a pan-cancer cohort of patients with mTOR pathway aberrations. Seventy-one...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032789/ https://www.ncbi.nlm.nih.gov/pubmed/35454843 http://dx.doi.org/10.3390/cancers14081936 |